Chemed (CHE) Depreciation Expense (2009 - 2026)

Chemed has reported Depreciation Expense for 18 years, with the latest figure at $14.3 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation Expense rose 6.38% year-over-year to $14.3 million; the trailing twelve-month figure through Mar 2026 stood at $55.4 million (up 4.51% YoY), and the FY2025 full-year result was $54.6 million, up 3.2% from the prior year.
• Depreciation Expense for Q1 2026 stood at $14.3 million, up from $13.8 million in the prior quarter.
• The five-year high for Depreciation Expense was $14.3 million in Q1 2026, with the low at $12.1 million in Q4 2022.
• Average Depreciation Expense over 5 years is $13.0 million, with a median of $13.1 million recorded in 2024.
• Year-over-year, Depreciation Expense fell 6.6% in 2022 and rose 8.15% in 2024.
• Tracing CHE's Depreciation Expense over 5 years: stood at $12.1 million in 2022, then gained by 7.67% to $13.0 million in 2023, then increased by 1.84% to $13.3 million in 2024, then gained by 3.74% to $13.8 million in 2025, then increased by 3.95% to $14.3 million in 2026.
• The last three Depreciation Expense figures came in at $14.3 million (Q1 2026), $13.8 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.

Peer Comparison